150% Dividend: Smallcap Tata Stock Soars Over 10% As RBI Rejects Tata Sons' IPO Exemption Appeal; BUY?

Tata Chemicals, a smallcap stock from the Tata Group, saw a sharp rally in trade today, October 21, surging over 14% at its peak to reach Rs 1,244.70 per share on the Bombay Stock Exchange (BSE). The bullish movement in Tata Chemicals' stock follows a crucial decision by the Reserve Bank of India (RBI), which rejected Tata Sons' appeal for an exemption from the mandatory listing of its shares.

The RBI's ruling, according to Zee Business Research, is seen as a positive signal for Tata Chemicals. Tata Sons, the primary investment holding company of the Tata Group, is now required to list its shares by September 2025. This impending stock market debut is considered a potential growth catalyst for Tata Group entities, including Tata Chemicals.

In 2023, the RBI classified Tata Sons as an 'upper-layer' non-banking financial company (NBFC). Under the RBI's regulations, such entities are mandated to be listed on stock exchanges within three years of the notification. With the deadline looming, Tata Sons has been exploring ways to delay or avoid the listing, but the recent rejection by the RBI solidifies the likelihood of its market debut next year.

Tata Sons has been working to maintain its status as a closely held entity, trying to circumvent the mandatory listing requirement. In August 2024, Tata Sons repaid over Rs 20,000 crore in debt, a move that was intended to prevent the listing. Additionally, in September 2024, Tata Sons turned down an Initial Public Offering (IPO) proposal from the Shapoorji Pallonji Group, one of its key shareholders.

The company had also sought approval from the RBI to give up its registration as a non-banking financial company and instead operate as an unregistered core investment company (CIC). This transition would have allowed Tata Sons to continue as an unlisted entity, but the RBI's latest decision puts that plan to rest.

The ripple effect of the RBI's decision had an immediate impact on Tata Chemicals' stock. By 1:25 pm on the National Stock Exchange (NSE), Tata Chemicals was trading with gains of approximately 10.50%, at Rs 1,200.40 per share. This sudden surge stands in contrast to the stock's overall performance in the past year, where it had delivered modest returns of around 8%.

Market analysts believe that the RBI's decision to enforce Tata Sons' listing may result in higher valuations for Tata Group companies, including Tata Chemicals, as it could unlock significant value for shareholders.

As Tata Sons prepares for its stock market debut, the listing is expected to be a landmark event. For Tata Chemicals, the positive market sentiment tied to this development has already spurred significant investor interest, and if Tata Sons' listing results in higher valuations across the Tata Group, Tata Chemicals shareholders could stand to benefit.